Ab­bVie, North­west­ern to col­lab­o­rate on can­cer re­search

Modern Healthcare - - REGIONAL NEWS - —Kris­ten Schorsch, Crain’s Chicago Busi­ness

Phar­ma­ceu­ti­cal gi­ant Ab­bVie and North­west­ern Univer­sity have agreed to a five-year deal to col­lab­o­rate on can­cer re­search.

As part of the agree­ment, sci­en­tists at North­west­ern’s Lurie Can­cer Cen­ter will be able to ac­cess new ther­a­pies de­vel­oped by North Chicago-based Ab­bVie for re­search funded un­der the deal. Ab­bVie will be able to ex­clu­sively li­cense any dis­cov­er­ies made dur­ing the col­lab­o­ra­tion.

“One of the best steps Ab­bVie can take to de­liver new ther­a­pies in on­col­ogy is to com­bine our re­search and dis­cov­ery ex­per­tise with the tal­ents and in­sight of our col­leagues in aca­demic medicine,” said Dr. Gary Gor­don, Ab­bVie’s vice pres­i­dent of on­col­ogy clin­i­cal de­vel­op­ment, in a joint state­ment an­nounc­ing the deal.

Ab­bVie an­nounced a sim­i­lar col­lab­o­ra­tion to­day with Johns Hop­kins Univer­sity School of Medicine in Bal­ti­more, of which Gor­don is an alum­nus and for­mer fac­ulty mem­ber, as well as one ear­lier this year with the Univer­sity of Chicago.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.